Oberhaching, April 2022
Dear Sir or Madam,
Today, we are informing you about a personnel change at Lyomark Pharma GmbH and Bendalis GmbH.
Mr Parvany will be leaving the companies on 31 March 2022. Mr Parvany has been employed by both companies since 2012, initially as Head of Sales and Marketing and as Managing Director since 2019.
We would like to take this opportunity to sincerely thank Mr. Parvany for his significant commitment over the past few years, which has significantly contributed to the company's success. We wish him all the best for the future.
From 1 April 2022, Dr. Dirk Hütten will join the management team, alongside Dr. Burger. Dr. Hütten has over 20 years of experience in various international sales roles along the pharmaceutical product supply chain.
We are delighted to have gained Dr. Dirk Hütten as Managing Director and wish him every success.
The shareholders of Lyomark Pharma GmbH and Bendalis GmbH